A comparison of the antihypertensive and metabolic effects of lisinopril 20 mg/hydrochlorothiazide 12.5 mg fixed combination with captopril 50 mg/hydrochlorothiazide 25 mg fixed combination;COMPARAISON DES EFFETS ANTIHYPERTENSEUR ET METABOLIQUES DE L'ASSOCIATION FIXE LISINOPRIL 20 MG/HYDROCHLOROTHIAZIDE 12.5 MG ET DE L'ASSOCIATION FIXE CAPTOPRIL 50 MG/HYDROCHLOROTHIAZIDE 25 MG

Therapie

Volumn 52, Issue 3, 1997, Pages 195-205

  Milon, H ^a   Baleydier, A ^b  

^a CROIX ROUSSE HOSPITAL   (France)

^b RCTs   (France)

Author keywords

Ambulatory blood pressure monitoring; Angiotensin concerting enzyme inhibition; Antihypertensive treatment; Diuretic; Lisinopril hydrochlorothiazide combination

Indexed keywords

CAPTOPRIL; HYDROCHLOROTHIAZIDE; LISINOPRIL; PLACEBO; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; POTASSIUM; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; AMBULATORY MONITORING; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CHOLECYSTITIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG MIXTURE; EPIGASTRIC PAIN; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART RATE; HEMATOCRIT; HOME MONITORING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID URINE LEVEL; VERTIGO; BLOOD; BLOOD PRESSURE; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; MIDDLE AGED;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAPTOPRIL; DIURETICS; DRUG COMBINATIONS; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; LISINOPRIL; MALE; MIDDLE AGED; POTASSIUM; SODIUM CHLORIDE SYMPORTER INHIBITORS; TRIGLYCERIDES;

EID: 0030613667     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Zanchetti A, Chalmers J, Arakawa K and the Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. 1993 Guidelines for the management of mild hypertension. Memorandum from a World Health Organization / International Society of Hypertension Meeting (Chantilly, France, 28-31 mars 1993). Hypertension 1993; 22: 392-403.
2. Materson BJ, Reda DJ, Cushman WC and the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Department of Veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Am J Hypertens 1995; 8: 189-192.
3. Taylor Nelson Healthcare. Copyright CardioMonitor 1992.
4. Gifford RW and the Joint National Committee on detection, evaluation and treatment of high blood pressure. The fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (JNC V). Arch Intern Med 1993; 153: 154-183.
5. Menard J. Critical assessment of combination therapy development. Blood Pressure 1993; 2 suppl. 1: 5-9.
6. Holland OB, Von Kuhnert L, Campbell WB et al. Synergistic effect of captopril plus hydrochlorothiazide for the treatment of low renin hypertensive black patients. Hypertension 1983; 5: 235-240.
7. Tuck ML, Katz LA, Kirkendall NM. Low dose captopril in mild to moderate geriatric hypertension. J Am Geriatr Soc 1986; 34: 693-696.
8. Pool JL, Gennari J, Goldstein R et al. Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension. Cardiovasc Pharmacol 1987; 9 suppl. 3: S36-S42.
9. Townsend RR, Holland OB. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension. Arch Intern Med 1990; 150: 1175-1183.
10. Miller E. Introduction to lisinopril-hydrochlorothiazide combination. J Hum Hypertens 1991; 5 suppl. 2: 49-51.
11. Andren L, Weiner L, Svensson A, Hansson L. Enalapril with either a 'very low' or 'low' dose of hydrochlorothiazide is equally effective in essential hypertension. A double-blind trial in 100 hypertensive patients. J Hypertens 1983; 1 suppl. 2: 384-386.
12. Weinberger MH. Blood pressure and metabolic response to hydrochlorothiazide, captopril and the combination in black and white mild to moderate hypertensive patients. J Cardiovasc Pharmacol 1985; 7 suppl. 1: S52-S55.
13. Ambrosioni E, Borghi C, Costa FV. Captopril and hydrochlorothiazide : rationale for their combination. Br J Clin Pharmacol 1987; 23: 43S-50S.
14. Canter D, Franck GJ, Knapp LE et al. Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. J Hum Hypertens 1994; 8: 155-162.
15. Siscovick DS, Raghunathan TE, Psaty BM et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994; 330: 1852-1857.
16. Duchin KL, Singhvi SM, Willard DA et al. Captopril kinetics. Clin Pharmacol Ther 1982; 31: 452-458.
17. Ulm EH, Hichens M, Gomez HJ, Till AE et al. Enalapril maleate and a lysine analogue (MK-521): disposition in man. Br J Clin Pharmacol 1982; 14: 357-362.
18. Biollaz J, Schelling JL, Jacot Des Combes B et al. Enalapril aleate and a lysine analogue (MK-521) in normal volunteers. Relationship between plasma drug levels and the renin angiotensin system. Br J Clin Pharmacol 1982; 14: 363-368.
19. Beermann B. Pharmacokinetics of lisinopril. Am J Med 1988; 85: 25-30.
20. Beermann B, Junggren I, Cocchetto D et al. Lisinopril steady state kinetics in healthy subjects. J Clin Pharmacol 1985; 25: 471.
21. Beermann B, Groschinsky-Grind M. Pharmacokinetics of hydrochlorothiazide in patients with congestive heart failure. Br J Clin Pharmacol 1979; 7: 579-583.
22. Graham RD. Treating mild-to-moderate hypertension: a comparison of lisinopril-hydrochlorothiazide fixed combination with captopril and hydrochlorothiazide free combination. J Hum Hypertens 1991; 5 suppl. 2: 59-61.
23. Rappelli A. Controlling hypertension: lisinopril-hydrochlorothiazide vs captopril-hydrochlorothiazide. An Italian multicentre study. J Hum Hypertens 1991; 5 suppl. 2: 55-58.
24. Vaïsse B, Renucci JF, Delage Y et al. Evaluation de l'efficacité antihypertensive du lisinopril et du captopril associés à l'hydrochlorothiazide par mesure ambulatoire de la pression artérielle. Ann Cardiol Angéiol 1993; 42: 566-572.
25. Andersson OK, Gudbrandsson T, Jamerson K. Metabolic adverse effects of thiazide diuretics: the importance of normokalaemia. J Intern Med 1991; 229 suppl. 2: 89-96.
26. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial: risk factor changes and mortality results. JAMA 1982; 248: 1465-1477.
27. Ames RP. Metabolic disturbances increasing the risk of coronary heart disease during diuretic-based antihypertensive therapy: lipid alterations and glucose intolerance. Am Heart J 1983; 106: 1207-1215.
28. Weinberger MH. Mechanisms of diuretic effects on carbohydrate tolerance, insulin sensitivity and lipid levels. Eur Heart J 1992; 13 suppl. G: 5-9.
29. Weinberger MH. Influence of an angiotensin-converting enzyme inhibitor on diuretic-induced metabolic effects in hypertension. Hypertension 1983; 5 (suppl. 2): 132-138.
30. Gomez HJ, Smith SC, Walker JF, Zupkis R. Lisinopril appears to attenuate the hypokalemia and hyperuricemia produced by hydrochlorothiazide. J Clin Pharmacol 1988; 28: 938.
31. Leonetti G. Comparaison des effets métaboliques et hémodynamiques de l'hydrochlorothiazide en monothérapie et de l'association hydrochlorothiazide + lisinopril. Min Cardioangiol 1995; 43: 389-398
32. Muller JE, Stone PH, Turi ZG et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313: 1315-1322.
33. Willich SN, Levy D, Rocco MB et al. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987; 60: 801-806.
34. Quyyumi AA. Circadian rhythms in cardiovascular disease. Am Heart J 1990; 120: 726-733.
35. Herrlin B, Nyquist O, Sylvén C. Induction of a reduction in haemoglobin concentration by enalapril in stable, moderate heart failure: a double blind study. Br Heart J 1991; 66: 199-205.
36. Pratt MC, Lewis-Barned NJ, Walker RJ et al. Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers. Br J Clin Pharmacol 1992; 34: 363-365.
37. Sizeland, PCB, Bailey RR, Lynn KL, Robson RA. Anemia and angiotensin-converting enzyme inhibition in renal transplant recipients. J Cardiovasc Pharmacol 1990; 16 suppl. 7: S117-S119.